These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 17275428

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Intestinal transplantation with alemtuzumab (Campath-1H) induction for adult patients.
    Nishida S, Levi DM, Moon JI, Madariaga JR, Kato T, Selvaggi G, Tryphonopoulos P, DeFaria W, Santiago S, Gaynor J, Weppler D, Martinez E, Ruiz P, Tzakis AG.
    Transplant Proc; 2006; 38(6):1747-9. PubMed ID: 16908270
    [Abstract] [Full Text] [Related]

  • 23. Preliminary experience with alemtuzumab induction therapy combined with maintenance low-dose tacrolimus monotherapy in small-bowel transplantation in China.
    Yuan-Xin L, Ning L, You-Sheng L, Xiao-Dong N, Ming L, Jian W, Jie-Shou L.
    Transplant Proc; 2010; 42(1):29-34. PubMed ID: 20172275
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The efficacy and safety of alemtuzumab and daclizumab versus antithymocyte globulin during organ transplantation: a meta-analysis.
    Hao WJ, Zong HT, Cui YS, Zhang Y.
    Transplant Proc; 2012 Dec; 44(10):2955-60. PubMed ID: 23195005
    [Abstract] [Full Text] [Related]

  • 35. Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy.
    McCurry KR, Iacono A, Zeevi A, Yousem S, Girnita A, Husain S, Zaldonis D, Johnson B, Hattler BG, Starzl TE.
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):528-37. PubMed ID: 16077423
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Induction therapy for clinical intestinal transplantation: comparison of four different regimens.
    Pinna AD, Weppler D, Nery JR, Khan F, Ruiz P, Kato T, De Faria W, Berho M, Tzakis AG.
    Transplant Proc; 2000 Sep; 32(6):1193-4. PubMed ID: 10995902
    [No Abstract] [Full Text] [Related]

  • 38. Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody.
    Beniaminovitz A, Itescu S, Lietz K, Donovan M, Burke EM, Groff BD, Edwards N, Mancini DM.
    N Engl J Med; 2000 Mar 02; 342(9):613-9. PubMed ID: 10699160
    [Abstract] [Full Text] [Related]

  • 39. The incidence of acute cellular rejection after lung transplantation: a comparative study of anti-thymocyte globulin and daclizumab.
    Burton CM, Andersen CB, Jensen AS, Iversen M, Milman N, Boesgaard S, Arendrup H, Eliasen K, Carlsen J.
    J Heart Lung Transplant; 2006 Jun 02; 25(6):638-47. PubMed ID: 16730569
    [Abstract] [Full Text] [Related]

  • 40. Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab.
    Kimura T, Lauro A, Cescon M, Zanfi C, Dazzi A, Ercolani G, Grazi GL, Vivarelli M, Ravaioli M, Del Gaudio M, Cucchetti A, Zanello M, LaBarba G, Pironi L, Lazzarotto T, Pinna AD.
    Clin Transplant; 2009 Jun 02; 23(3):420-5. PubMed ID: 19537304
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.